BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Atanasov G, Schierle K, Hau HM, Dietel C, Krenzien F, Brandl A, Wiltberger G, Englisch JP, Robson SC, Reutzel-Selke A, Pascher A, Jonas S, Pratschke J, Benzing C, Schmelzle M. Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma. Ann Surg Oncol 2017;24:518-25. [PMID: 27480355 DOI: 10.1245/s10434-016-5472-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zhang W, Ge H, Wu J, Sun X, Sun K, Cao W, Zhang Q, Liang T. Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.. [DOI: 10.21203/rs.3.rs-2086751/v1] [Reference Citation Analysis]
2 Yoo J, Cha Y, Park H, Park M, Joo B, Suh S, Ahn S. The Extent of Necrosis in Brain Metastases May Predict Subtypes of Primary Cancer and Overall Survival in Patients Receiving Craniotomy. Cancers 2022;14:1694. [DOI: 10.3390/cancers14071694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tsilimigras DI, Pawlik TM. ASO Author Reflections: Impact of Tumor Necrosis on Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2022. [PMID: 35217976 DOI: 10.1245/s10434-022-11464-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Bahna M, Heimann M, Bode C, Borger V, Eichhorn L, Güresir E, Hamed M, Herrlinger U, Ko YD, Lehmann F, Potthoff AL, Radbruch A, Schaub C, Surges R, Weller J, Vatter H, Schäfer N, Schneider M, Schuss P. Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom. Neurosurg Rev 2021. [PMID: 33988803 DOI: 10.1007/s10143-021-01560-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Li W, Lu H, Wang H, Zhang H, Sun X, Hu L, Zhao W, Gu Y, Li H, Wang D. Salvage Endoscopic Nasopharyngectomy in Recurrent Nasopharyngeal Carcinoma: Prognostic Factors and Treatment Outcomes. Am J Rhinol Allergy 2021;35:458-66. [PMID: 33019819 DOI: 10.1177/1945892420964054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
6 Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM. Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma. Ann Transplant 2020;25:e919414. [PMID: 32165607 DOI: 10.12659/AOT.919414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Park WK, Joshi PK, Lee KW, Lee KB, Hong SK, Yoon KC, Lee JM, Cho JH, Yi NJ, Suh KS. Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma. Transplant Proc 2020;52:271-5. [PMID: 31926744 DOI: 10.1016/j.transproceed.2019.09.013] [Reference Citation Analysis]
8 Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World J Surg Oncol 2019;17:217. [PMID: 31830991 DOI: 10.1186/s12957-019-1756-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
9 Atanasov G, Dino K, Schierle K, Dietel C, Aust G, Pratschke J, Seehofer D, Schmelzle M, Hau HM. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes. World J Surg Oncol 2019;17:97. [PMID: 31170995 DOI: 10.1186/s12957-019-1635-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Fang T, Wang H, Wang Y, Lin X, Cui Y, Wang Z. Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma. Dis Markers. 2019;2019:6016931. [PMID: 30863466 DOI: 10.1155/2019/6016931] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
11 Atanasov G, Dietel C, Feldbrügge L, Benzing C, Krenzien F, Brandl A, Katou S, Schierle K, Robson SC, Splith K, Wiltberger G, Reutzel-Selke A, Jonas S, Pascher A, Bahra M, Pratschke J, Schmelzle M. Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma. Oncotarget 2018;9:29921-33. [PMID: 30042823 DOI: 10.18632/oncotarget.25699] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Atanasov G, Dietel C, Feldbrügge L, Benzing C, Krenzien F, Brandl A, Mann E, Englisch JP, Schierle K, Robson SC, Splith K, Morgul MH, Reutzel-Selke A, Jonas S, Pascher A, Bahra M, Pratschke J, Schmelzle M. Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma. Oncoimmunology 2017;6:e1331806. [PMID: 28919993 DOI: 10.1080/2162402X.2017.1331806] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]